<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39469096</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6973</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Infection and drug resistance</Title><ISOAbbreviation>Infect Drug Resist</ISOAbbreviation></Journal><ArticleTitle>MERS-CoV Infection and Its Impact on the Expression of TSLP Cytokine and IgG Antibodies: An In Vivo and In Vitro Study.</ArticleTitle><Pagination><StartPage>4589</StartPage><EndPage>4598</EndPage><MedlinePgn>4589-4598</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IDR.S483133</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Thymic stromal lymphopoietin (TSLP) is a proinflammatory cytokine produced by epithelial cells that is involved in the activation of allergic disorders. To date, no study has examined TSLP induction during Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Herein, we aimed to study the effects of the recombinant spike protein of MERS-CoV on TSLP production. Additionally, the effects of recombinant human TSLP (rhTSLP) on B cell survival and antibody production were investigated.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">B cells were separated using the Human B Cell Enrichment Kit, and B cell survival was measured using the WST-1 Assay Kit. Enzyme-linked immunosorbent assay (ELISA) was used to measure TSLP levels in the sera of both MERS-CoV-infected (n=4; median age, 53 years) and healthy individuals (n=5; median age, 35 years).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We showed that the group of infected patients had significantly higher levels of TSLP than healthy controls (37.6 pg/mL vs 19.8 pg/mL, *<i>p</i>&lt;0.05). The levels of TSLP in A549 cells were remarkably increased after 48 h of stimulation with recombinant full-length spike protein (rSP) (32.2 pg/mL, <i>p</i>=0.01). B cell survival was greatly enhanced by rhTSLP alone or in combination with rSP (0.02 vs 0.046, and 0.045; <i>**p</i>&lt;0.01, respectively). Our data also showed a significant synergistic effect of rhTSLP and rSP on the augmented response of IgG antibodies against the spike protein of MERS-CoV compared with unstimulated cells (0.156 vs 0.22; <i>*p</i>&lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">TSLP production is induced in vivo after MERS-CoV infection and in vitro after treatment with the rSP of MERS-CoV, which has a significant effect on the survival of B cells. Our data suggest that TSLP can be used as a strong mucosal adjuvant for vaccine development against MERS-CoV infection. However, further investigation is required to study the functional role of TSLP in MERS-CoV infection.</AbstractText><CopyrightInformation>© 2024 Mubarak et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mubarak</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4948-5574</Identifier><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alqoufail</LastName><ForeName>Mahfoudh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almutairi</LastName><ForeName>Saeedah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alrfaei</LastName><ForeName>Bahauddeen</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5740-9187</Identifier><AffiliationInfo><Affiliation>Stem Cells Unit, Department of Cellular Therapy, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Science, MNGHA, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almotairi</LastName><ForeName>Abdulaziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine, Almaarefa University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-6970-5207</Identifier><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almanaa</LastName><ForeName>Taghreed N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Maksoud</LastName><ForeName>Mostafa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrag</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldreiwish</LastName><ForeName>Allolo D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, 11952, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awadalla</LastName><ForeName>Maaweya E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-1270-2216</Identifier><AffiliationInfo><Affiliation>Research Center, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alosaimi</LastName><ForeName>Bandar</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4719-2655</Identifier><AffiliationInfo><Affiliation>Research Center, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alturaiki</LastName><ForeName>Wael</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6947-7582</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, 11952, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Drug Resist</MedlineTA><NlmUniqueID>101550216</NlmUniqueID><ISSNLinking>1178-6973</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">MERS-CoV</Keyword><Keyword MajorTopicYN="N">TSLP</Keyword><Keyword MajorTopicYN="N">recombinants spike protein</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>4</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39469096</ArticleId><ArticleId IdType="pmc">PMC11513571</ArticleId><ArticleId IdType="doi">10.2147/IDR.S483133</ArticleId><ArticleId IdType="pii">483133</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A.m Z, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. doi:10.1056/NEJMoa1211721</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211721</ArticleId><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Gossner C. Human-Dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection. Zoonoses Public Health. 2016;63(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7165574</ArticleId><ArticleId IdType="pubmed">25545147</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Azhar EI, Kim Y-J, et al. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18(8):e217–e227. doi:10.1016/S1473-3099(18)30127-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30127-0</ArticleId><ArticleId IdType="pmc">PMC7164784</ArticleId><ArticleId IdType="pubmed">29680581</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauchemez S, Fraser C, Van Kerkhove MD, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014;14(1):50–56. doi:10.1016/S1473-3099(13)70304-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70304-9</ArticleId><ArticleId IdType="pmc">PMC3895322</ArticleId><ArticleId IdType="pubmed">24239323</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauchemez S, Nouvellet P, Cori A, et al. Unraveling the drivers of MERS-CoV transmission. Proc Natl Acad Sci USA. 2016;113(32):9081–9086. doi:10.1073/pnas.1519235113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1519235113</ArticleId><ArticleId IdType="pmc">PMC4987807</ArticleId><ArticleId IdType="pubmed">27457935</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC, European CDC. MERS-CoV worldwide overview. Available from: https://www.ecdc.europa.eu/en/middle-east-respiratory-syndrome-coronavirus-mers-cov-situation-update. Accessed September
10, 2024.</Citation></Reference><Reference><Citation>Mahallawi WH, Khabour OF, Zhang Q, et al. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;104:8–13. doi:10.1016/j.cyto.2018.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.01.025</ArticleId><ArticleId IdType="pmc">PMC7129230</ArticleId><ArticleId IdType="pubmed">29414327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tynell J, Westenius V, Rönkkö E, et al. Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. J Gen Virol. 2016;97(2):344–355. doi:10.1099/jgv.0.000351</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000351</ArticleId><ArticleId IdType="pmc">PMC4804640</ArticleId><ArticleId IdType="pubmed">26602089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindler E, Thiel V, Weber F. Interaction of SARS and MERS coronaviruses with the antiviral interferon esponse. Adv Virus Res. 2016;96:219–243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112302</ArticleId><ArticleId IdType="pubmed">27712625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralinski LE, Baric RS. Molecular pathology of emerging coronavirus infections. J Pathol. 2015;235(2):185–195. doi:10.1002/path.4454</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4454</ArticleId><ArticleId IdType="pmc">PMC4267971</ArticleId><ArticleId IdType="pubmed">25270030</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin HS, Kim Y, Kim G, et al. Immune responses to middle east respiratory syndrome coronavirus during the acute and convalescent phases of human infection. Clin Infect Dis. 2019;68(6):984–992. doi:10.1093/cid/ciy595</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy595</ArticleId><ArticleId IdType="pmc">PMC7108191</ArticleId><ArticleId IdType="pubmed">30060038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mella C, Suarez-Arrabal MC, Lopez S, et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2013;207(4):564–573. doi:10.1093/infdis/jis721</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis721</ArticleId><ArticleId IdType="pmc">PMC3611762</ArticleId><ArticleId IdType="pubmed">23204162</ArticleId></ArticleIdList></Reference><Reference><Citation>S.k.p L, Lau CCY, Chan K-H, et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013;94(Pt 12):2679–2690. doi:10.1099/vir.0.055533-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.055533-0</ArticleId><ArticleId IdType="pubmed">24077366</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadava K, Sichelstiel A, Luescher IF, et al. TSLP promotes influenza-specific CD8+ T-cell responses by augmenting local inflammatory dendritic cell function. Mucosal Immunol. 2013;6(1):83–92. doi:10.1038/mi.2012.50</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2012.50</ArticleId><ArticleId IdType="pmc">PMC3534170</ArticleId><ArticleId IdType="pubmed">22806096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims JE, Williams DE, Morrissey PJ, et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med. 2000;192(5):671–680. doi:10.1084/jem.192.5.671</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.192.5.671</ArticleId><ArticleId IdType="pmc">PMC2193273</ArticleId><ArticleId IdType="pubmed">10974033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler SF. The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol. 2013;66:129–155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169878</ArticleId><ArticleId IdType="pubmed">23433457</ArticleId></ArticleIdList></Reference><Reference><Citation>Alturaiki W. High plasma levels of the TSLP cytokine in Saudi patients with chronic stable asthma. J of King Saud Uni Sci. 2022;34(7):102271. doi:10.1016/j.jksus.2022.102271</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jksus.2022.102271</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheeren FA, van Lent AU, Nagasawa M, et al. Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation. Eur J Immunol. 2010;40(4):955–965. doi:10.1002/eji.200939419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200939419</ArticleId><ArticleId IdType="pubmed">20127673</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shami A, Spolski R, Kelly J, et al. A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med. 2004;200(2):159–168. doi:10.1084/jem.20031975</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20031975</ArticleId><ArticleId IdType="pmc">PMC2212020</ArticleId><ArticleId IdType="pubmed">15263024</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by γ family cytokines. Nat Rev Immunol. 2009;9(7):480–490. doi:10.1038/nri2580</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2580</ArticleId><ArticleId IdType="pmc">PMC2814538</ArticleId><ArticleId IdType="pubmed">19543225</ArticleId></ArticleIdList></Reference><Reference><Citation>West EE, Spolski R, Kazemian M, et al. A TSLP-complement axis mediates neutrophil killing of methicillin-resistant Staphylococcus aureus. Sci Immunol. 2016;1(5). doi:10.1126/sciimmunol.aaf8471</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aaf8471</ArticleId><ArticleId IdType="pmc">PMC8530006</ArticleId><ArticleId IdType="pubmed">28783679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Voisin B, Kim DY, et al. Homeostatic control of sebaceous glands by innate lymphoid cells regulates commensal bacteria equilibrium. Cell. 2019;176(5):982–997. doi:10.1016/j.cell.2018.12.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.12.031</ArticleId><ArticleId IdType="pmc">PMC6532063</ArticleId><ArticleId IdType="pubmed">30712873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebina-Shibuya R, Leonard WJ. Role of thymic stromal lymphopoietin in allergy and beyond. Nat Rev Immunol. 2023;23(1):24–37. doi:10.1038/s41577-022-00735-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00735-y</ArticleId><ArticleId IdType="pmc">PMC9157039</ArticleId><ArticleId IdType="pubmed">35650271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita H, Takai T, Anh Le T, et al. Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA. J Allergy Clin Immunol. 2009;123(1):179–186. doi:10.1016/j.jaci.2008.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2008.10.008</ArticleId><ArticleId IdType="pubmed">19056108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubarak A, Alrfaei B, Aljurayyan A, et al. In vivo and in vitro evaluation of cytokine expression profiles during middle east respiratory syndrome Coronavirus (MERS-CoV) infection. J Inflamm Res. 2021;14:2121–2131. doi:10.2147/JIR.S312337</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S312337</ArticleId><ArticleId IdType="pmc">PMC8149276</ArticleId><ArticleId IdType="pubmed">34045884</ArticleId></ArticleIdList></Reference><Reference><Citation>Alturaiki W. Considerations for novel COVID-19 mucosal vaccine development. Vaccines. 2022;10(8):1173. doi:10.3390/vaccines10081173</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081173</ArticleId><ArticleId IdType="pmc">PMC9329946</ArticleId><ArticleId IdType="pubmed">35893822</ArticleId></ArticleIdList></Reference><Reference><Citation>Alturaiki W. Exploring the development of a promising mucosal adjuvant vaccine for human respiratory syncytial virus (RSV) infection. J of King Saud Uni Sci. 2024;36:103289. doi:10.1016/j.jksus.2024.103289</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jksus.2024.103289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Headley MB, Loo Y-M, et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol. 2012;130(5):1187–1196. doi:10.1016/j.jaci.2012.07.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.07.031</ArticleId><ArticleId IdType="pmc">PMC4284103</ArticleId><ArticleId IdType="pubmed">22981788</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Wei H, Morihara J, et al. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol Oncol. 2012;127(2):412. doi:10.1016/j.ygyno.2012.07.098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2012.07.098</ArticleId><ArticleId IdType="pmc">PMC3472044</ArticleId><ArticleId IdType="pubmed">22828962</ArticleId></ArticleIdList></Reference><Reference><Citation>Astrakhan A, Omori M, Nguyen T, et al. Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development. Nat Immunol. 2007;8(5):522–531. doi:10.1038/ni1452</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1452</ArticleId><ArticleId IdType="pubmed">17401368</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Roey GA, Arias MA, Tregoning JS, et al. Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice. Eur J Immunol. 2012;42(2):353–363. doi:10.1002/eji.201141787</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201141787</ArticleId><ArticleId IdType="pmc">PMC3378695</ArticleId><ArticleId IdType="pubmed">22057556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L, Schnepf D, Ohnemus A, et al. Interferon-lambda improves the efficacy of intranasally or rectally administered influenza subunit vaccines by a thymic stromal lymphopoietin-dependent mechanism. Front Immunol. 2021;12:749325. doi:10.3389/fimmu.2021.749325</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.749325</ArticleId><ArticleId IdType="pmc">PMC8511795</ArticleId><ArticleId IdType="pubmed">34659250</ArticleId></ArticleIdList></Reference><Reference><Citation>Alturaiki W. The role of cross-reactive immunity to emerging coronaviruses: implications for novEl Universal mucosal vaccine design. Saudi Med J. 2023;44(10):965–972. doi:10.15537/smj.2023.44.10.20230375</Citation><ArticleIdList><ArticleId IdType="doi">10.15537/smj.2023.44.10.20230375</ArticleId><ArticleId IdType="pmc">PMC10541972</ArticleId><ArticleId IdType="pubmed">37777266</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Wu X, Peng Y, et al. TSLP promoting B cell proliferation and polarizing follicular helper T cell as a therapeutic target in IgG4-related disease. J Transl Med. 2022;20(1):414. doi:10.1186/s12967-022-03606-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03606-1</ArticleId><ArticleId IdType="pmc">PMC9461269</ArticleId><ArticleId IdType="pubmed">36076269</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattarini L, Trichot C, Bogiatzi S, et al. TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand. J Exp Med. 2017;214(5):1529–1546. doi:10.1084/jem.20150402</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20150402</ArticleId><ArticleId IdType="pmc">PMC5413322</ArticleId><ArticleId IdType="pubmed">28428203</ArticleId></ArticleIdList></Reference><Reference><Citation>Elder MJ, Webster SJ, Williams DL, et al. TSLP production by dendritic cells is modulated by IL‐1β and components of the endoplasmic reticulum stress response. Eur j Immunol. 2016;46(2):455–463. doi:10.1002/eji.201545537</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545537</ArticleId><ArticleId IdType="pmc">PMC4783504</ArticleId><ArticleId IdType="pubmed">26573878</ArticleId></ArticleIdList></Reference><Reference><Citation>Milford TAM, Su RJ, Francis OL, et al. TSLP or IL‐7 provide an IL‐7Rα signal that is critical for human B lymphopoiesis. Eur j Immunol. 2016;46(9):2155–2161. doi:10.1002/eji.201646307</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646307</ArticleId><ArticleId IdType="pmc">PMC5056642</ArticleId><ArticleId IdType="pubmed">27325567</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>